Coleen Glessner serves as Executive at Emergent BioSolutions Inc., where they oversee executive responsibilities. Since joining the company, Coleen Glessner has executed 15 insider transactions totaling $306.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 6, 2026 involved selling 2,852 shares valued at $31.1K.
Coleen Glessner currently holds 112,620 shares of Emergent BioSolutions Inc. (EBS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Coleen Glessner has been a net seller of EBS stock. They have purchased $0 and sold $306.1K worth of shares.
Coleen Glessner's most recent insider trade was on Feb 6, 2026, when they sold 2,852 shares at $10.92 per share.
Get notified when new Form 4 filings are submitted
| $10.92 |
| Discretionary |
| Oct 7, 2025 | EBS | $306.1K | Sale | 30,608 | $10.00 | Discretionary |
| Jun 8, 2024 | EBS | $7.7K | Payment | 1,249 | $6.19 | Discretionary |
| Apr 7, 2024 | EBS | $1.3K | Payment | 585 | $2.29 | Discretionary |
| Mar 1, 2024 | EBS | $1.3K | Payment | 381 | $3.39 | Discretionary |
| Jun 9, 2023 | EBS | $0 | Award | 15,385 | $N/A | Discretionary |
| Jun 9, 2023 | EBS | $0 | Award | 30,770 | $N/A | Discretionary |
| Apr 7, 2023 | EBS | $0 | Payment | 480 | $N/A | Discretionary |
| Mar 2, 2023 | EBS | $0 | Award | 7,692 | $N/A | Discretionary |
| Mar 2, 2023 | EBS | $0 | Award | 3,846 | $N/A | Discretionary |
| Dec 9, 2022 | EBS | $0 | Award | 24,078 | $N/A | Discretionary |
| Dec 9, 2022 | EBS | $0 | Award | 72,232 | $N/A | Discretionary |
| Apr 8, 2022 | EBS | $0 | Award | 5,913 | $N/A | Discretionary |
| Apr 8, 2022 | EBS | $0 | Award | 5,913 | $N/A | Discretionary |